Skip to main content
CivicGate

HR 1060
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Modern Authentication of Pharmaceuticals Act of 2025

To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

Introduced Feb 6, 2025

Latest action (Feb 6, 2025) Referred to the House Committee on Energy and Commerce.

Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to modernize authentication methods for controlled substances in the pharmaceutical distribution supply chain. Beginning five years after enactment, controlled substances in solid oral dosage form must include a physical chemical identifier on each dose to authenticate the product. The bill updates definitions to allow product identifiers to include either standardized graphics with human-readable and machine-readable data (product number, lot number, expiration date), or physical chemical identifiers (unique physical or chemical substances that are machine-readable). The bill also updates verification procedures to allow authentication using either traditional product identifier data or the new physical chemical identifier method.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Actions (3)

  1. Feb 6, 2025 Referred to the House Committee on Energy and Commerce. · house
  2. Feb 6, 2025 Introduced in House
  3. Feb 6, 2025 Sponsor introductory remarks on measure. (CR H519)

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Text versions (1)

  • Introduced in House · Feb 6, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

February 6, 2025

Mr. Davis of North Carolina (for himself, Mr. Rutherford, and Mr. Bacon) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Modern Authentication of Pharmaceuticals Act of 2025”.

SEC. 2. MODERNIZING THE AUTHENTICATION OF CONTROLLED SUBSTANCES IN THE PHARMACEUTICAL DISTRIBUTION SUPPLY CHAIN.

(a) In General.—Section 582(a)(9) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee-1(a)(9)) is amended—

(1) in subparagraph (A)(ii), by striking “and” at the end;

(2) by redesignating subparagraph (B) as subparagraph (C); and

(3) by inserting after subparagraph (A) the following:

“(B) a physical chemical identifier shall be included in or on each dose of a product that is—

“(i) a controlled substance (as defined in section 102 of the Controlled Substances Act);

“(ii) in solid oral dosage form; and

“(iii) manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025; and”.

(b) Conforming Changes.—

(1) Section 581(14) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(14)) is amended to read as follows:

“(14) Product identifier.—The term ‘product identifier’ means—

“(A) a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or

“(B) a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—

“(i) is in or on a product;

“(ii) is machine readable; and

“(iii) is intended to authenticate the product or a dosage form thereof.”.

(2) Section 581(28) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(28)) is amended to read as follows:

“(28) Verification or verify.—The term ‘verification’ or ‘verify’ means—

“(A) determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or

“(B) determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B).”. <all>

Comments

Comments

Loading comments…